Synthesis of Oxazinyl Analogues of Fosmidomycin Using RCM Methodology

Abstract

Fosmidomycin is a promising antimalarial compound with a novel mode of action, the inhibition of 1-deoxy-d-xylulose 5-phosphate reductoisomerase, a key enzyme in the biosynthesis of isoprenoids through the nonmevalonate pathway. This paper describes the synthesis of a series of analogues in which the hydroxamate moiety is incorporated in a ring structure, leaving the complexation with the enzyme up to the oxygen lone pairs instead of the free hydroxyl group. The antimalarial activities of the different analogues are currently under investigation.

fosmidomycin - oxazinyl analogues - 1-deoxy-d-xylulose 5-phosphate reductoisomerase - ring-closing metathesis - heterogeneous ruthenium catalysis

References and notes

1

Aspirant of the Fund for Scientific Research, Flanders (FWO, Vlaanderen), Belgium.

2 Thayer A. Chem. Eng. News  2005,  83 (October 24):  69 

3 Missinou M. Borrmann S. Schindler A. Issifou S. Adegnika A. Matsiegui P. Binder R. Lell B. Wiesner J. Baranek T. Jomaa H. Kremsner P. Lancet  2002,  360:  1941 

4 Lell B. Ruangweerayut R. Wiesner J. Missinou M. Schindler A. Baranek T. Hintz M. Hutchinson D. Jomaa H. Kremsner P. Antimicrob. Agents Chemother.  2003,  47:  735 

5 Wiesner J. Ortmann R. Jomaa H. Schlitzer M. Angew. Chem. Int. Ed.  2003,  42:  5274 

6 Tsuchiya T. Ishibashi K. Terakawa M. Nishiyama M. Itoh N. Noguchi H. Eur. J. Drug. Metab. Pharmacokinet.  1982,  7:  59 

7a Kuemmerle HP. Murakawa T. De Santis F. Chemioterapia  1987,  6:  113 

7b Kuemmerle HP. Murakawa T. Sakamoto H. Sato N. Konishi T. De Santis F. Int. J. Clin. Pharmacol. Ther. Toxicol.  1985,  23:  521 

8 Reuter K. Sanderbrand S. Jomaa H. Wiesner J. Steinbrecher I. Beck E. Hintz M. Klebe G. Stubbs MT. J. Biol. Chem.  2002,  277:  5378 

9 Reichenberg A. Wiesner J. Weidemeyer C. Dreiseidler E. Sanderbrand S. Altincicek B. Beck E. Schlitzer M. Jomaa H. Bioorg. Med. Chem. Lett.  2001,  11:  833 

10a Ortmann R. Wiesner J. Reichenberg A. Henschker D. Beck E. Jomaa H. Schlitzer M. Arch. Pharm. Chem. Life Sci.  2005,  338:  305 

10b Ortmann R. Wiesner J. Reichenberg A. Henschker D. Beck E. Jomaa H. Schlitzer M. Bioorg. Med. Chem. Lett.  2003,  13:  2163 

11 Kurz T. Schlüter K. Kaula U. Bergmann B. Walter RD. Geffken D. Bioorg. Med. Chem.  2006,  14:  5121 

12 Kurz T. Geffken D. Wackendorff C. Z. Naturforsch., B  2003,  58b:  457 

13 Woo YH. Fernandes RPM. Proteau PJ. Bioorg. Med. Chem.  2006,  14:  2375 

14 Courtois M. Mincheva Z. Andreu F. Rideau M. Viaud-Massuard M. J. Enz. Inh. Med. Chem.  2004,  19:  559 

15 Mincheva Z. Courtois M. Andreu F. Rideau M. Viaud-Massuard MC. Phytochemistry  2005,  66:  1797 

16 Kuntz L. Tritsch D. Grosdemange-Billiard C. Hemmerlin A. Willem A. Bacht TJ. Rohmer M. Biochem. J.  2005,  386:  127 

17 Devreux V. Wiesner J. Goeman JL. Van der Eycken J. Jomaa H. Van Calenbergh S. J. Med. Chem.  2006,  49:  2656 

18 Kurz T. Schlüter K. Pein M. Behrendt C. Bergmann B. Walter RD. Arch. Pharm. Chem. Life Sci.  2007,  340:  339 

19 Haemers T. Wiesner J. Busson R. Jomaa H. Van Calenbergh S. Eur. J. Org. Chem.  2006,  3856 

20a Haemers T. Wiesner J. Van Poecke S. Goeman J. Henschker D. Beck E. Jomaa H. Van Calenbergh S. Bioorg. Med. Chem. Lett.  2006,  16:  1888 

20b Devreux V. Wiesner J. Jomaa H. Rozenski J. Van der Eycken J. Van Calenbergh S. J. Org. Chem.  2007,  72:  3783 

21a Yang Y.-K. Tae J. Synlett  2003,  1043 

21b Miyabe H. Yoshida K. Matsumura A. Yamauchi M. Takemoto Y. Synlett  2003,  567 

21c Koide K. Finkelstein JM. Ball Z. Verdine GL. J. Am. Chem. Soc.  2001,  123:  398 

21d Le Flohic A. Meyer C. Cossy J. Desmurs JR. Tetrahedron Lett.  2003,  44:  8577 

21e Shustov GV. Chandler MK. Wolfe S. Can. J. Chem.  2005,  83:  93 

22 Van Meenen E. Moonen K. Verwee A. Stevens CV.
J. Org. Chem.  2006,  71:  7903 

23 Teulade M. Savignac P. Synthesis  1987,  1037 

24 Albrecht S. Defoin A. Tarnus C. Synthesis  2006,  1635 

25 Eguchi S. Furukawa Y. Suzuki T. Kondo K. Sasaki T. Honda M. Katayama C. Tanaka J. J. Org. Chem.  1985,  50:  1895 

26

Preparation of Diethyl 1-Phenyl-3-(4-methyl-3-oxo-3,6-dihydro-2 H -1,2-oxazin-2-yl)propylphosphonate (10b): A solution of 9b (1 g, 2.53 mmol) in anhyd CH₂Cl₂ (30 mL) was brought under a N₂ atmosphere. The mixture was stirred at reflux temperature and Grubbs’ second-generation catalyst (0.1073 g, 0.126 mmol) was added. After 6 h of refluxing, the solvents were evaporated under vacuum to yield the product 10b as a crude oil. Purification by column chromatography was necessary to remove the traces of the ruthenium catalyst, yielding 10b (0.70 g, 1.90 mmol, 75%). ¹H NMR (300 MHz, CDCl₃): δ = 1.08 (t, J = 7.0 Hz, 3 H, OEt), 1.29 (t, J = 7.0 Hz, 3 H, OEt), 1.88 (q, J = 1.7 Hz, 3 H, CMe), 2.22-2.35 (m, 1 H, CH_AH_BCHP), 2.40-2.54 (m, 1 H, CH_AH_BCHP), 3.11 (ddd, J = 3.1, 11.2, 23.1 Hz, 1 H, CHP), 3.46 (ddd, J = 6.7, 6.8, 14.0 Hz, 1 H, CH_AH_BN), 3.59 (ddd, J = 7.2, 7.2, 14.0 Hz, 1 H, CH_AH_BN), 3.66-4.11 (m, 4 H, 2 × OEt), 4.35 (ddq, J = 1.7, 3.5, 15.4 Hz, 1 H, OCH_AH_BCH=C), 4.44 (ddq, J = 1.7, 3.5, 15.4 Hz, 1 H, OCH_AH_BCH=C), 6.35 (tq, J = 1.7, 3.5 Hz, 1 H, OCH₂CH=C), 7.23-7.37 (m, 5 H, CH_arom). ¹³C NMR (75 MHz, CDCl₃, ref. CDCl₃): δ = 15.70 (CMe), 16.27, 16.35, 16.45, 16.54 (2 × OEt), 27.78 (J _C-P = 2.3 Hz, CH₂CHP), 42.33 (J _C-P = 138.5 Hz, CHP), 45.14 (J _C-P = 18.5 Hz, CH₂N), 61.97 (J _C-P = 6.9 Hz, OEt), 62.81 (J _C-P = 6.9 Hz, OEt), 67.54 (OCH₂CH=C), 77.13 (CDCl₃), 127.44 (J _C-P = 2.3 Hz, CH_arom), 128.67 (J _C-P = 2.3 Hz, 2 × CH_arom), 129.40 (J _C-P = 6.9 Hz, 2 × CH_arom), 129.67 (CMe), 132.92 (OCH₂CH=C), 135.48 (J _C-P = 6.9 Hz, C_q,arom), 166.46 (CO). ³¹P NMR (109 MHz, CDCl₃): δ = 28.92. IR (NaCl): 1674, 1635 (C=O, C=C), 1242 (P=O), 1058, 1028 (PO) cm^-1. MS (ESI, +ve mode, %): m/z = 368.3 (100) [M + H⁺]. Chromatography (PE-EtOAc, 1:4): R _f = 0.18.

27 For a summary of existing methods for removal of Ru species, see: Conrad JC. Fogg DE. Curr. Org. Chem.  2006,  10:  185 

28a Maynard HD. Grubbs RH. Tetrahedron Lett.  1999,  40:  4137 

28b Grubbs RH. Org. React. (N.Y.)  2004,  22:  123 

28c Ahn YM. Yang K. Georg GI. Org. Lett.  2001,  3:  1411 

28d Paquette LA. Schloss JD. Efremov I. Fabris F. Gallou F. Mendez-Andino J. Yang J. Org. Lett.  2000,  2:  1259 

28e McEleney K. Allen DP. Holliday AE. Crudden CM. Org. Lett.  2006,  8:  2663 

28f Galan BR. Kalbarczyk KP. Szczepankiewicz S. Keister JB. Diver ST. Org. Lett.  2007,  9:  1203 

28g Cho JH. Kim BM. Org. Lett.  2003,  5:  531 

29

Preparation of Diammonium 1-Phenyl-3-(4-methyl-3-oxo-3,6-dihydro-2 H -1,2-oxazin-2-yl)propylphos-phonate (1b): To a solution of 10b (0.50 g, 1.36 mmol) in anhyd MeCN at r.t. was added dropwise TMSBr (13.6 mmol) and this mixture was stirred at r.t. for 24 h. The solvents and traces of TMSBr were removed under reduced pressure and under high vacuum. The residual oil was dissolved in H₂O and the pH was adjusted with a 5% NH₄OH solution to pH 8-9. Lyophilization of the solution resulted in a solid and purification was performed by column chromatography on Whatman CF11 cellulose. The solvent used was MeCN-aq 1 M NH₄OH (5:1) and the fractions were analyzed on cellulose TLC with the use of UV light to visualize the spots after dipping the plates in a pinacryptol yellow solution (0.1% in H₂O) and drying with hot air. The desired fractions were again lyophilized, yielding 1b as a pale brown hygroscopic solid (0.31 g, 0.88 mmol, 65%). ¹H NMR (300 MHz, CDCl₃): δ = 1.72 (d, J = 1.7 Hz, 3 H, CMe), 2.14-2.42 (m, 2 H, CH₂CHP), 2.93 (ddd, J = 3.0, 11.8, 22.0 Hz, 1 H, CHP), 3.50 (t, J = 6.5 Hz, 2 H, CH₂N), 4.31 (ddd, J = 1.9, 3.6, 15.7 Hz, 1 H, OCH_AH_BCH=C), 4.44 (ddq, J = 1.9, 3.4, 15.7 Hz, 1 H, OCH_AH_BCH=C), 4.79 (D₂O), 6.45 (tq, J = 1.7, 1.7 Hz, 1 H, OCH₂CH=C), 7.19-7.35 (m, 5 H, 5 × CH_arom). ¹³C NMR (75 MHz, CDCl₃, ref. MeCN): δ = 1.47 (ref. MeCN), 15.20 (CMe), 28.13 (J _C-P = 2.3 Hz, CH₂CHP), 44.79 (J _C-P = 129.2 Hz, CHP), 45.94 (J _C-P = 17.3 Hz, CH₂N), 68.24 (OCH₂CH=C), 119.69 (ref. MeCN), 127.17 (J _C-P = 2.3 Hz, CH_arom), 128.36 (CMe), 129.00 (J _C-P = 2.3 Hz, 2 × CH_arom), 129.69 (J _C-P = 6.9 Hz, 2 × CH_arom), 135.26 (OCH₂CH=C), 139.14 (J _C-P = 6.9 Hz, C_q,arom), 166.73 (CO). ³¹P NMR (109 MHz, CDCl₃): δ = 22.91. IR (NaCl): 1668 (C=O, C=C), 1033 (PO) cm^-1. MS (ESI, -ve mode, %): m/z = 310.3 (100) [M - ⁺NH₄ - NH₃]. Chromatography (MeCN-1 M NH₄OH, 5:1): R _f = 0.16.